ftInvstr

NEPHROPLUS · Healthcare ₹622.95 +0.57% Mkt Cap ₹6252 Cr overvalued

NEPHROPLUS

Healthcare Medical Care Facilities

★ Watchlist ⧉ Add to bucket

₹622.95

+0.57% today · 30d +0.72%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for NEPHROPLUS. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-09-30

REVENUE

₹303 Cr

NET PROFIT

₹34 Cr

OPM

24.12%

EPS

₹3.34

PE 49.72

Intrinsic value · DCF ₹59.97 · Margin of safety -90.4% (overvalued) · FCF yield 1.82%

◇ Sector Position

PEERPEROCE %

NEPHROPLUS49.7215.0

APOLLOHOSP60.8425.39

MAXHEALTH64.6615.72

FORTIS54.7415.53

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance — —

Valuation FAIR 40

Growth STRONG 72

Profitability HIGH 78

Technicals WEAK 47

Risk LOW 90

Key Stats

TTM PE

49.72

P/B

5.67

52W HIGH

₹781.5

OFF HIGH

-20.29%

DIV YIELD

0.0%

MKT CAP

₹6252 Cr

◉ Active Signals

MACDNeutral3.8789

RSI(14)Neutral47.22

Street Consensus

5 analysts

₹798.0

mean target

Low ₹730.0Now ₹622.95High ₹920.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NEPHROPLUS and at what entry.